Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Immunologic Research
Published in: Immunologic Research 1/2017

Open Access 01-02-2017 | Environment and Autoimmunity

Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature

Authors: Maartje J. L. Colaris, Mintsje de Boer, Rene R. van der Hulst, Jan Willem Cohen Tervaert

Published in: Immunologic Research | Issue 1/2017

Login to get access

Abstract

In this study, we compared one hundred patients with autoimmune/inflammatory syndrome induced by adjuvants (ASIA) due to silicone implant incompatibility syndrome diagnosed in 2014 in Maastricht, the Netherlands, with one hundred historical patients with adjuvant breast disease diagnosed in the Baylor College of Medicine, Houston, USA, between 1985 and 1992. Similarities and differences between these two cohorts were identified to determine whether the spectrum of silicone-related disease changed during the last 30 years. Patients with complaints possibly due to silicone-filled breast implants were prospectively examined in the Reinaert Clinic, Maastricht, the Netherlands between January 2014 and October 2014. All patients were evaluated for the fulfilment of ASIA criteria. Results were compared to results of the Baylor College cohort and 18 other reviewed historical cohorts. Clinical manifestations between the Maastricht and Baylor College cohorts were comparable. Fatigue was observed in 98 current patients and in 95 historical patients. Arthralgia was observed in 91 versus 81 historical patients. Myalgia was observed in 54 versus 91 patients. Cognitive impairment was observed in 78 versus 81 patients, pyrexia was observed in 64 versus 52 patients, sicca complaints in 73 versus 72 patients and severe neurological manifestations in 20 versus 32 patients. From the 54 patients who underwent removal of their silicone breast implant, 50 % (n = 27) of the patients experienced improvement of complaints after explantation of the implant. Also, in the 18 reviewed historical cohorts, similar clinical manifestations were described. Our findings suggest that no major changes were present in the observed clinical manifestations between the Maastricht and Baylor College cohorts. Also, despite changes in the principal constituents of the silicone implants during the past fifty years, silicone remained an adjuvant that may ‘bleed’ and subsequently may be a chronic stimulus to the immune system resulting in similar clinical manifestations as observed in the Maastricht cohort, the Baylor College cohort and 18 other large cohorts of patients. We therefore conclude that silicone-related disease has not changed during the last 30 years.
Literature
1.
The American Society for Aesthetic Plastic Surgery. National Plastic Surgery Statistics Editor. California: The American Society for Aesthetic Plastic Surgery. 2009.
2.
Miyoshi K, Miyamura T, Kobayashi Y, Itakura T, Nishijo K. Hyper-gammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammaplasty. Jpn Med J. 1964;2122:9–14.
3.
Cohen Tervaert JW, Kappel RM. Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld’s syndrome). Immunol Res. 2013;56:293–8.CrossRefPubMed
4.
Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y. Silicone and scleroderma revisited. Lupus. 2012;21:121–7.CrossRefPubMed
5.
Levy Y, Rotman-Pikielny P, Ehrenfeld M, Shoenfeld Y. Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus. 2009;18:1226–32.CrossRefPubMed
6.
Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease: a comprehensive review. Autoimmunity. 2003;36:193–7.CrossRefPubMed
7.
Zandman-Goddard G, Ehrenfeld M, Shoenfeld Y. Silicone implants for breast augmentation and autoimmune diseases. Harefuah. 1993;125:360–4.PubMed
8.
Ehrenfeld M, Shoenfeld Y. Breast silicone implant and autoimmunity: coincidence or cause and effect relationship? Harefuah. 1998;134:361–4.PubMed
9.
Jewell M, Spear SL, Largent J, Oefelein MG, Adams WP Jr. Anaplastic large T-cell lymphoma and breast implants: a review of the literature. Plast Reconstr Surg. 2011;128:651–61.CrossRefPubMed
10.
Bizjak M, Selmi C, Praprotnik S, Bruck O, Perricone C, Ehrenfeld M, Shoenfeld Y. Silicone implants and lymphoma: the role of inflammation. J Autoimmun. 2015;65:64.CrossRefPubMed
11.
Kadin ME, Deva A, Xu H, Morgan J, Khare P, MacLeod RA, van Natta BW, Adams WP Jr, Brody GS, Epstein AL. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016
12.
Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000;342:781–90.CrossRefPubMed
13.
14.
Shoenfeld Y, Agmon-Levin N. ‘ASIA’-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36:4–8.CrossRefPubMed
15.
Maijers MC, de Blok CJ, Niessen FB, van der Veldt AA, Ritt MJ, Winters HA, et al. Women with silicone breast implants and unexplained systemic symptoms: a descriptive cohort study. Neth J Med. 2013;71:534–40.PubMed
16.
Shoaib BO, Patten BM, Calkins DS. Adjuvant breast disease: an evaluation of 100 symptomatic women with breast implants or silicone fluid injections. Keio J Med. 1994;43:79–87.CrossRefPubMed
17.
Tervaert JW, Van Paassen P, Damoiseaux J. Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience. Ann N Y Acad Sci. 2007;1107:251–8.CrossRefPubMed
18.
19.
Avery TY, van de Cruys M, Austen J, Stals F, Damoiseaux JG. Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care. J Immunol Res. 2014;2014:401739.CrossRefPubMedPubMedCentral
20.
De Steenwinkel FD, Hokken-Koelega AC, de Ridder MA, Hazes JM, Dolhain RJ. Rheumatoid arthritis during pregnancy and postnatal catch-up growth in the offspring. Arthritis Rheumatol. 2014;66:1705–11.CrossRefPubMed
21.
Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med. 1993;118:929–36.CrossRefPubMed
22.
Peters W, Smith D, Fornasier V, Lugowski S, Ibanez D. An outcome analysis of 100 women after explantation of silicone gel breast implants. Ann Plast Surg. 1997;39:9–19.CrossRefPubMed
23.
Contant CM, Swaak AJ, Obdeijn AI, van der Holt B, Tjong Joe Wai R, van Geel AN. A prospective study on silicone breast implants and the silicone-related symptom complex. Clin Rheumatol. 2002;21(3):215–9.CrossRefPubMed
24.
Contant CM, Swaak AJ, Wiggers T, Wai RT, van Geel AN. First evaluation study of the Dutch Working Party on silicone breast implants (SBI) and the silicone-related symptom complex (SRSC). Clin Rheumatol. 2000;19(6):458–63.CrossRefPubMed
25.
Shoaib BO, Patten BM. Human adjuvant disease: presentation as a multiple sclerosis-like syndrome. South Med J. 1996;89(2):179–88.CrossRefPubMed
26.
Cuellar ML, Gluck O, Molina JF, Gutierrez S, Garcia C, Espinoza R. Silicone breast implant–associated musculoskeletal manifestations. Clin Rheumatol. 1995;14(6):667–72.CrossRefPubMed
27.
Gaubitz M, Jackisch C, Domschke W, Heindel W, Pfleiderer B. Silicone breast implants: correlation between implant ruptures, magnetic resonance spectroscopically estimated silicone presence in the liver, antibody status and clinical symptoms. Rheumatol (Oxford). 2002;41(2):129–35.CrossRef
28.
Giltay EJ, Bernelot Moens HJ, Riley AH, Tan RG. Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study. Ann Rheum Dis. 1994;53(3):194–6.CrossRefPubMedPubMedCentral
29.
De Jong WH, Goldhoorn CA, Kallewaard M, Geertsma RE, Van Loveren H, Bijlsma JW, Schouten JS. Study to determine the presence of antipolymer antibodies in a group of Dutch women with a silicone breast implant. Clin Exp Rheumatol. 2002;20(2):151–60.PubMed
30.
Englert H, Joyner E, Thompson M, Garcia H, Chambers P, Horner D, Hunt C, Makaroff J, O’Connor H, Russell N, March L. Augmentation mammoplasty and “silicone-osis”. Intern Med J. 2004;34(12):668–76.CrossRefPubMed
31.
Vasey FB, Havice DL, Bocanegra TS, Seleznick MJ, Bridgeford PH, Martinez-Osuna P, Espinoza LR. Clinical findings in symptomatic women with silicone breast implants. Semin Arthritis Rheum. 1994;24(1 Suppl 1):22–8.CrossRefPubMed
32.
Vermeulen RC, Scholte HR. Rupture of silicone gel breast implants and symptoms of pain and fatigue. J Rheumatol. 2003;30(10):2263–7.PubMed
33.
Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med. 1993;118(12):929–36.CrossRefPubMed
34.
Freundlich B, Altman C, Snadorfi N, Greenberg M, Tomaszewski J. A profile of symptomatic patients with silicone breast implants: a Sjögrens-like syndrome. Semin Arthritis Rheum. 1994;24((1 Suppl 1)):44–53.CrossRefPubMed
35.
Solomon G. A clinical and laboratory profile of symptomatic women with silicone breast implants. Semin Arthritis Rheum. 1994;24(1 Suppl 1):29–37.CrossRefPubMed
36.
Melmed EP. A review of explantation in 240 symptomatic women: a description of explantation and capsulectomy with reconstruction using a periareolar technique. Plast Reconstr Surg. 1998;101(5):1364–73.CrossRefPubMed
37.
Wells KE, Roberts C, Daniels SM, Kearney RE, Cox CE. Psychological and rheumatic symptoms of women requesting silicone breast implant removal. Ann Plast Surg. 1995;34(6):572–7.CrossRefPubMed
38.
Bennet RM, Jones J, Turk DC, Russel IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;9:8–27.
39.
Rodriguez-Rodriguez L, Ramon Lamas J, Abasolo L, et al. The rs3771863 single nucleotide polymorphism of th TACR1gene is associated to a lower risk of sicca syndrome in fibromyalgia patients. Clin Exp Rheumatol Suppl. 2015;33(Suppl 88):S33–40.
40.
Wolfe F. Silicone related symptoms” are common in patients with fibromyalgia: no evidence for a new disease. J Rheumatol. 1999;26(5):1172–5.PubMed
41.
42.
Agmon-Levin N, Shoenfeld Y. Chronic fatigue syndrome with autoantibodies—the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev. 2008;8:52–5.CrossRef
43.
44.
Soriano A, Butnaru D, Shoenfeld Y. Long-term inflammatory conditions following silicone exposure: the expanding spectrum of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Clin Exp Rheumatol. 2014;32:151–4.PubMed
Metadata
Title
Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature
Authors
Maartje J. L. Colaris
Mintsje de Boer
Rene R. van der Hulst
Jan Willem Cohen Tervaert
Publication date
01-02-2017
Publisher
Springer US
Published in
Immunologic Research / Issue 1/2017
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-016-8821-y

Other articles of this Issue 1/2017

Immunologic Research 1/2017 Go to the issue

Therapeutic Aspects in Autoimmunity

Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure

Mechanism in Autoimmunity

Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?

Environment and Autoimmunity

Autoimmune reaction after anti-tetanus vaccination—description of four cases and review of the literature

Environment and Autoimmunity

Electrosmog and autoimmune disease

Environment and Autoimmunity

Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures

Mechanism in Autoimmunity

Pathophysiology and laboratory diagnosis of pernicious anemia